Kashiv BioSciences and MS Pharma Enter into MENA License and Supply Agreement for ADL-018, Biosimilar Candidate to XOLAIR® (bOmalizumab)
Business Wire India Kashiv BioSciences, LLC and MS Pharma today announced that the companies have entered into a license and…